跳至主要内容
临床试验/NCT01460147
NCT01460147终止不适用

Bone and Joint Health in an Adult Hemophilia Population

Baxalta now part of Shire2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2011年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
2
主要终点
Longitudinal Endpoint: Change in bone mineral density by DXA over 2 years

研究概览

简要总结

The purpose of this study is to evaluate bone mineral density in adult subjects with hemophilia versus a comparator population without hemophilia (non-hemophilia age- and gender-matched database) by using the following diagnostic means: dual-energy X-ray absorptiometry (DXA) scanning, clinical scales, quality of life (QOL) scales and biomarkers. In addition to this osteoporosis study, hemophilic arthropathy of the knee with respect to loss of knee cartilage will also be explored by using magnetic resonance imaging (MRI substudy). No investigational product will be dispensed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male and at least 25 years old at the time of screening
  • Moderately severe or severe hemophilia A or B (factor VIII or factor IX <= 2% by chart documentation)
  • Ambulatory (ie, not wheel chair dependent)
  • Performance status - ECOG of 0 or 1 (= out of bed at least 75% of time)
  • Willing and able to comply with the requirements of the protocol and is able to give informed consent
  • Additional inclusion criteria for MRI Substudy:
  • Baseline knee joint space width is >= 3mm at the medial or lateral aspect of either knee as measured by weightbearing fixed flexion PA X-ray
  • Able to undergo 1.5 or 3T MRI

排除标准

  • Inability to position properly for DXA
  • Presence of orthopedic hardware or other artifact in the lumbar spine (L1-L4) or either proximal femur
  • Prior documentation of being HIV positive
  • Radiosynovectomy or surgical synovectomy within the last 6 months
  • Current or past treatment with bone active drugs
  • Long-term corticosteroid use [defined as 7.5-mg prednisone daily (or equivalent) for >= 3 months]
  • If subject is family member or employee of the investigator
  • Additional exclusion criteria for MRI Substudy:
  • Any contraindication or relative contraindication to MRI
  • Less than 3mm knee joint space width at the medial and lateral aspect of both knees on baseline X-ray evaluation
  • Knee bleed within 30 days of informed consent
  • Prior total knee arthroplasty (TKA)

结局指标

主要结局

Longitudinal Endpoint: Change in bone mineral density by DXA over 2 years

时间窗: 2 years

Longitudinal Endpoint: Rate of loss of knee cartilage parameters over 2 years by MRI

时间窗: 2 years

Baseline Endpoint: Z-Score by dual-energy X-ray absorptiometry (DXA) at baseline

时间窗: Baseline

次要结局

未报告次要终点

研究者

发起方
Baxalta now part of Shire
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验